Distinguished in E Coli Enteritis

Andreas M. Petersen

Copenhagen, DK 
Distinguished in E Coli Enteritis
Copenhagen, DK 
OverviewLocationsClinical Research

Overview

Andreas Petersen practices in Copenhagen, Denmark. Mr. Petersen is rated as a Distinguished expert by MediFind in the treatment of E Coli Enteritis. His top areas of expertise are E Coli Enteritis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Ulcerative Colitis, Hemorrhagic Proctocolitis, and Appendectomy.

His clinical research consists of co-authoring 172 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of E Coli Enteritis.

Gender
Male

Locations

Copenhagen, Denmark
Other Locations
Hvidovre, 2650, Denmark
Denmark
Frederiksberg, 1870, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease: a Double-blind, Randomized, Placebo-controlled Study
The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease: a Double-blind, Randomized, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
The Effect of a Lactobacillus Probiotic Strain on Eradication of Vancomycin Resistant Enterococcus Faecium (VRE) in Non-symptomatic VRE-carriers - a Multicenter, Randomized, Placebo-controlled, Parallel-group Study With 4 Weeks Intervention
The Effect of a Lactobacillus Probiotic Strain on Eradication of Vancomycin Resistant Enterococcus Faecium (VRE) in Non-symptomatic VRE-carriers - a Multicenter, Randomized, Placebo-controlled, Parallel-group Study With 4 Weeks Intervention
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: July 06, 2023
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 2 Less Clinical Trials

172 Total Publications

Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024.
Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: July 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Petersen's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile